Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintanance of lymphoblastoid cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 51, 2006, Pages 19500-19505

  Maruo, Seiji ^a   Wu, Yi ^a   Ishikawa, Satoko ^a   Kanda, Teru ^a   Iwakiri, Dai ^a   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Oncogenic virus; p16; Retinoblastoma protein

Indexed keywords

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; EPSTEIN BARR VIRUS; LYMPHOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; VIRUS INFECTION; VIRUS RECOMBINANT;

B-LYMPHOCYTES; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLOW CYTOMETRY; GENETIC COMPLEMENTATION TEST; HUMANS; IMMUNOPRECIPITATION; RETINOBLASTOMA PROTEIN; TAMOXIFEN;

HUMAN HERPESVIRUS 4;

EID: 33845900225     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0604919104     Document Type: Article

References (47)

1. Rickinson AB, Kieff E (2001) in Fields Virology, eds Knipe DM, Howley PM (Lippincott, Philadelphia), Vol 2, pp 2575-2628.
2. Henle W, Diehl V, Kohn G, zur Hausen H, Henle G (1967) Science 157:1064-1065.
3. Kieff E, Rickinson AB (2001) in Fields Virology, eds Knipe DM, Howley PM (Lippincott, Philadelphia), Vol 2, pp 2511-2574.
4. Joab I, Rowe DT, Bodescot M, Nicolas JC, Farrell PJ, Perricaudet M (1987) J Virol 61:3340-3344.
5. Shimizu N, Yamaki M, Sakuma S, Ono Y, Takada K (1988) Int J Cancer 41:744-751.
6. Petti L, Kieff E (1988) J Virol 62:2173-2178.
7. Petti L, Sample J, Wang F, Kieff E (1988) J Virol 62:1330-1338.
8. Ricksten A, Kallin B, Alexander H, Dillner J, Fahraeus R, Klein G, Lerner R, Rymo L (1988) Proc Natl Acad Sci USA 85:995-999.
9. Jiang H, Cho YG, Wang F (2000) J Virol 74:5921-5932.
10. Rivailler P, Jiang H, Cho YG, Quink C, Wang F (2002) J Virol 76:421-426.
11. Rivailler P, Cho YG, Wang F (2002) J Virol 76:12055-12068.
12. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E (1995) J Virol 69:3108-3116.
13. Robertson ES, Lin J, Kieff E (1996) J Virol 70:3068-3074.
14. Waltzer L, Perricaudet M, Sergeant A, Manet E (1996) J Virol 70:5909-5915.
15. Zhao B, Marshall DR, Sample CE (1996) J Virol 70:4228-4236.
16. Maruo S, Johannsen E, Illanes D, Cooper A, Zhao B, Kieff E (2005) J Virol 79:10171-10179.
17. Tomkinson B, Robertson E, Kieff E (1993) J Virol 67:2014-2025.
18. Tomkinson B, Kieff E (1992) J Virol 66:2893-2903.
19. Maruo S, Johannsen E, Illanes D, Cooper A, Kieff E (2003) J Virol 77:10437-10447.
20. Chen A, DiVisconte M, Jiang X, Quink C, Wang F (2005) J Virol 79:4506-4509.
21. Johannsen E, Miller CL, Grossman SR, Kieff E (1996) J Virol 70:4179-4183.
22. Radkov SA, Bain M, Farrell PJ, West M, Rowe M, Allday MJ (1997) J Virol 71:8552-8562.
23. Allday MJ, Farrell PJ (1994) J Virol 68:3491-3498.
24. Zhao B, Sample CE (2000) J Virol 74:5151-5160.
25. Lin J, Johannsen E, Robertson E, Kieff E (2002) J Virol 76:232-242.
26. Rosendorff A, Illanes D, David G, Lin J, Kieff E, Johannsen E (2004) J Virol 78:367-377.
27. Radkov SA, Touitou R, Brehm A, Rowe M, West M, Kouzarides T, Allday MJ (1999) J Virol 73:5688-5697.
28. Knight JS, Lan K, Subramanian C, Robertson ES (2003) J Virol 77:4261-4272.
29. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ (2001) J Virol 75:7749-7755.
30. Knight JS, Robertson ES (2004) J Virol 78:1981-1991.
31. Knight JS, Sharma N, Kalman DE, Robertson ES (2004) J Virol 78:12857-12867.
32. Knight JS, Sharma N, Robertson ES (2005) Mol Cell Biol 25:1749-1763.
33. Knight JS, Sharma N, Robertson ES (2005) Proc Natl Acad Sci USA 102:18562-18566.
34. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI (1995) Nucleic Acids Res 23:1686-1690.
35. Kanda T, Yajima M, Ahsan N, Tanaka M, Takada K (2004) J Virol 78:7004-7015.
36. Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E (1987) Proc Natl Acad Sci USA 84:3452-3456.
37. Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B (1999) J Virol 73:4481-4484.
38. Zhao B, Maruo S, Cooper A, Chase MR, Johannsen E, Kieff E, Cahir-McFarland E (2006) Proc Natl Acad Sci USA 103:1900-1905.
39. Cooper A, Johannsen E, Maruo S, Cahir-McFarland E, Illanes D, Davidson D, Kieff E (2003) J Virol 77:999-1010.
40. Serrano M, Hannon GJ, Beach D (1993) Nature 366:704-707.
41. Sherr CJ, Roberts JM (1999) Genes Dev 13:1501-1512.
42. Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G (1993) Oncogene 8:1049-1054.
43. Erlandsson F, Linnman C, Ekholm S, Bengtsson E, Zetterberg A (2000) Exp Cell Res 259:86-95.
44. Tan X, Wang JY (1998) Trends Cell Biol 8:116-120.
45. Parker GA, Crook T, Bain M, Sara EA, Farrell PJ, Allday MJ (1996) Oncogene 13:2541-2549.
46. Ahsan N, Kanda T, Nagashima K, Takada K (2005) J Virol 79:4415-4424.
47. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, Takada K (2000) EMBO J 19:6742-6750.